240 related articles for article (PubMed ID: 31591455)
1. The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis.
Ge Y; Shi Q; Yao W; Cheng Y; Ma G
Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):53-58. PubMed ID: 31591455
[TBL] [Abstract][Full Text] [Related]
2. Association between inflammatory bowel disease and risk of incident prostate cancer: a systematic review and meta-analysis of cohort studies.
Zhou BG; Yu Q; Jiang X; Mei YZ; Ding YB; Wang M
Int J Colorectal Dis; 2023 Jun; 38(1):168. PubMed ID: 37310514
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease and risk of urinary cancers: a systematic review and pooled analysis of population-based studies.
Feng D; Yang Y; Wang Z; Wei W; Li L
Transl Androl Urol; 2021 Mar; 10(3):1332-1341. PubMed ID: 33850767
[TBL] [Abstract][Full Text] [Related]
4. Risk of renal cancer in patients with inflammatory bowel disease: A pooled analysis of population-based studies.
Feng D; Bai Y; Liu S; Yang Y; Han P; Wei W
Urol Oncol; 2021 Feb; 39(2):93-99. PubMed ID: 33214029
[TBL] [Abstract][Full Text] [Related]
5. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis.
Chen Y; Wang X
Brain Behav; 2021 Jun; 11(6):e02159. PubMed ID: 33960728
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of herpes zoster infection in patients with inflammatory bowel disease: a meta-analysis of cohort studies.
Ning L; Liu R; Li S; Shan G; Du H; Zhang J; Chen W; Zhang F; Yu J; Xu G
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):219-227. PubMed ID: 31650411
[TBL] [Abstract][Full Text] [Related]
8. An increase in prostate cancer diagnosis during inflammatory bowel disease: A systematic review and meta-analysis.
Chen M; Yuan C; Xu T
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):302-309. PubMed ID: 31447293
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis.
Carli E; Caviglia GP; Pellicano R; Fagoonee S; Rizza S; Astegiano M; Saracco GM; Ribaldone DG
Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32545154
[No Abstract] [Full Text] [Related]
10. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis.
Chen Y; Chen L; Xing C; Deng G; Zeng F; Xie T; Gu L; Yang H
BMC Gastroenterol; 2020 Jun; 20(1):192. PubMed ID: 32552882
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease and risk of breast cancer: a meta-analysis of cohort studies.
Gong C; Xu R; Zou P; Zhang Y; Wang X
Eur J Cancer Prev; 2022 Jan; 31(1):54-63. PubMed ID: 34871199
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis and inflammatory bowel diseases: a systematic review and meta-analysis.
Kosmidou M; Katsanos AH; Katsanos KH; Kyritsis AP; Tsivgoulis G; Christodoulou D; Giannopoulos S
J Neurol; 2017 Feb; 264(2):254-259. PubMed ID: 27878439
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease and prostate cancer risk: A systematic review.
Haddad A; Al-Sabbagh MQ; Al-Ani H; Siyam AM; Aborajooh E; Iwata T; Kimura S; Shariat SF; Abufaraj M
Arab J Urol; 2020 May; 18(4):207-212. PubMed ID: 33312730
[No Abstract] [Full Text] [Related]
14. Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study.
Jung YS; Han M; Park S; Kim WH; Cheon JH
J Crohns Colitis; 2017 Aug; 11(8):954-962. PubMed ID: 28333358
[TBL] [Abstract][Full Text] [Related]
15. Risk of Urinary Bladder Cancer in Patients With Inflammatory Bowel Diseases: A Meta-Analysis.
Geng Z; Geng Q
Front Surg; 2021; 8():636791. PubMed ID: 34124132
[TBL] [Abstract][Full Text] [Related]
16. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
[TBL] [Abstract][Full Text] [Related]
17. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
18. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
20. Risk of uterine cervical cancer in inflammatory bowel disease: a systematic review and meta-analysis.
Kim J; Jung JH; Jo H; Kim MH; Kang DR; Kim HM
Scand J Gastroenterol; 2023; 58(12):1412-1421. PubMed ID: 37517000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
